Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICCBBA is an international nonprofit standards organization that develops, manages, and licenses the ISBT 128 Standard for medical products of human origin. Its work focuses on globally harmonized terminology, unique identification, coding, labeling, and electronic data exchange for products such as blood, cells, tissues, organs, milk, and related human-derived medical products. The organization serves healthcare providers, regulators, software vendors, and product vendors rather than operating a therapeutic drug pipeline. ICCBBA’s core business is standards development, education, registration and licensing, and support for global traceability and patient safety. It operates in official relations with the World Health Organization and supports adoption of its standard across dozens of countries and thousands of facilities worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICCBBA.